Disruption of TSC1/2 signaling complex reveals a checkpoint governing thymic CD4+CD25+Foxp3+, regulatory T-cell development in mice

被引:36
|
作者
Chen, Hui [1 ]
Zhang, Lianjun [1 ]
Zhang, Hongbing [2 ,3 ,4 ]
Xiao, Yi [1 ]
Shao, Lijuan [5 ]
Li, Hongran [1 ]
Yin, Hui [1 ]
Wang, Ruoyu [5 ]
Liu, Guangwei [1 ]
Corley, Douglas [1 ]
Yang, Zhongzhou [6 ]
Zhao, Yong [1 ]
机构
[1] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100101, Peoples R China
[2] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Physiol & Pathophysiol, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China
[3] Chinese Acad Med Sci, Sch Basic Med, Beijing 100730, Peoples R China
[4] Peking Union Med Coll, Beijing 100021, Peoples R China
[5] Dalian Univ, Dept Oncol, Affiliated Zhongshan Hosp, Dalian 116012, Peoples R China
[6] Nanjing Univ, Minist Educ Key Lab Model Anim Dis Study, Model Anim Res Ctr, Nanjing 210008, Jiangsu, Peoples R China
来源
FASEB JOURNAL | 2013年 / 27卷 / 10期
关键词
mTOR; thymus; Rictor; TUMOR-SUPPRESSOR TSC1; MAMMALIAN TARGET; RAPAMYCIN; MTOR; DIFFERENTIATION; CYCLOSPORINE; QUIESCENCE; EXPRESSION; MAINTAINS; SURVIVAL;
D O I
10.1096/fj.13-235408
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Thymic-derived CD4(+)CD25(+)Foxp3(+) natural regulatory T (nT(reg)) cells are essential for the maintenance of peripheral immune tolerance. Signaling pathways that drive immature thymic progenitors to differentiate into CD4(+)CD25(+)Foxp3(+) nT(reg) cells need to be elucidated. The precise role of the TSC1/2 complex, a critical negative regulator of mammalian target of rapamycin (mTOR), in thymic CD4(+)CD25(+)Foxp3(+) nT(reg)-cell development remains elusive. In the present study, we found that the percentage and cell number of thymic CD4(+)CD25(+)Foxp3(+) nT(reg) cells were significantly increased in T-cell-specific TSC1-knockout (TSC1KO) mice. Nevertheless, the levels of CD4(+)CD25(+)Foxp3(-) nT(reg) precursors in TSC1KO thymus were indistinguishable from those in wild-type mice. TSC1KO CD4(+)CD25(+)Foxp3(+) nT(reg) cells showed normal cell death but enhanced proliferative response to IL-2 in a STAT5-dependent manner. Rapamycin (Rapa) treatment failed to rescue but rather increased the frequency of CD4(+)CD25(+)Foxp3(+) nT(reg) cells in TSC1KO and RictorKO mice. The percentage and cell number of thymic CD4(+)CD25(+)Foxp3(+) nT(reg) cells were significantly increased in T-cell-specific RictorKO mice but not in PtenKO mice. Collectively, our studies suggest that TSC1 plays an important role in regulating thymic CD4(+)CD25(+)Foxp3(+) nT(reg)-cell development via a Rapa-resistant and mTORC2-dependent signaling pathway.Chen, H, Zhang, L., Zhang, H., Xiao, Y., Shao, L., Li, H., Yin, H., Wang, R., Liu, G., Corley, D., Yang, Z., Zhao, Y. Disruption of TSC1/2 signaling complex reveals a checkpoint governing thymic CD4(+)CD25(+)Foxp3(+) regulatory T-cell development in mice.
引用
收藏
页码:3979 / 3990
页数:12
相关论文
共 50 条
  • [21] Dissecting the Role of Galectin-1 in CD4+CD25+FOXP3+ Regulatory T Cells
    Sanchez, E.
    del Busto, P.
    Bueren, J.
    Garin, M.
    HUMAN GENE THERAPY, 2009, 20 (09) : 1076 - 1077
  • [22] Indirubin Increases CD4+CD25+Foxp3+ Regulatory T Cells to Prevent Immune Thrombocytopenia in Mice
    Zhang, Aijun
    Ning, Bin
    Sun, Nianzheng
    Wei, Jianlu
    Ju, Xiuli
    PLOS ONE, 2015, 10 (11):
  • [23] CD4+CD25+FOXP3+ regulatory T-cells and the development of active tuberculosis in humans.
    Hougardy, Jean-Michel
    Place, Sammy
    Leloux, Gaetle
    Temmerman, Stephane
    Debrie, Anne-Sophie
    Locht, Camille
    Mascart, Francoise
    CLINICAL IMMUNOLOGY, 2006, 119 : S20 - S20
  • [24] SUPPRESSION OF HUMAN NATURAL KILLER T CELL FUNCTION BY CD4+CD25+FOXP3+ REGULATORY T CELLS
    Venken, K.
    Decruy, T.
    Deswarte, K.
    Aspeslagh, S.
    Van Calenbergh, S.
    Lambrecht, B.
    Elewaut, D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (04) : 614 - 614
  • [25] Effect of Azacitidine on CD4+CD25+Foxp3+ Regulatory T Cell on Immunity in Myelodysplastic Syndrome Survivors
    Tajima, Fumihito
    Adachi, Koji
    Mochida, Hiroshi
    Kawatani, Toshio
    Suzumiya, Junji
    BLOOD, 2017, 130
  • [26] Increased numbers of thymic and peripheral CD4+CD25+Foxp3+ cells in the absence of CD5 signaling
    Ordonez-Rueda, Diana
    Lozano, Francisco
    Sarukhan, Adelaida
    Raman, Chander
    Garcia-Zepeda, Eduardo A.
    Soldevila, Gloria
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2009, 39 (08) : 2233 - 2247
  • [27] Functional deficit in CD4+CD25+Foxp3+ regulatory T cells in multiple sclerosis
    Zang, Ying C. Q.
    Hong, Jian
    Skinner, Sheri M.
    Zhang, Jingwu Z.
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 : 195 - 195
  • [28] Frequency and function of CD4+CD25+FOXP3+ regulatory T cells in atopic dermatitis
    Gaspar, Krisztian
    Barath, Sandor
    Nagy, Georgina
    Gyimesi, Edit
    Sipka, Sandor
    Zeher, Margit
    Remenyik, Eva
    Szegedi, Andrea
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S40 - S40
  • [29] Induction of alternatively activated macrophages by CD4+CD25+Foxp3+ regulatory T cells
    Jagger, A. L.
    Tiemessen, M. M.
    Taams, L. S.
    IMMUNOLOGY, 2008, 125 : 5 - 5
  • [30] CHARACTERISATION OF REGULATORY T CELLS (CD4+CD25+FOXP3+) IN RENAL TRANSPLANT RECIPIENTS
    Xu, Lin Wen
    Bo, Mioduszewski
    Mauro, Sandrin
    Francesco, Ierino
    IMMUNOLOGY AND CELL BIOLOGY, 2009, 87 (06): : A5 - A5